Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.052 | 0.9 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |